Actively Recruiting
Cardio-Oncology Registry
Led by European Georges Pompidou Hospital · Updated on 2020-05-29
5000
Participants Needed
1
Research Sites
543 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cardio-oncology is an emerging field. Most of the data available have been issued from either retrospective analysis, industry data or pharmacovigilance data. These data sources include a number of bias. CONFUCIUS is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt. The objectives are to provide a comprehensive vue of cardoi-oncology, enable to detect early signals of cardiotoxicity and enhance ancillary projetcts aiming at specific populations (e.g., type of cancer) and/or drugs.
CONDITIONS
Official Title
Cardio-Oncology Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Referred to cardio-oncology assessment
You will not qualify if you...
- Refusal to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Assistance Publique Hôpitaux de Paris - Centre Université de Paris
Paris, France, 75015
Actively Recruiting
Research Team
M
Mariana Mirabel, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here